Can-Fite BioPharma Ltd. CANF
TASE · Israel · Health Technology
ILA 330.80+1.40 (+0.43%)
Market closed· · ILA · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · ILA · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | 2026-09-08 | -1.85 | -0.49 | -275.8% | ILS 601.28K | — | -5.3%ILS 370.50→ILS 350.70 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.